Shuttle Pharmaceuticals Holdings Inc (SHPH)
0.4049
-0.01
(-1.77%)
USD |
NASDAQ |
May 17, 16:00
0.4049
0.00 (0.00%)
After-Hours: 20:00
Shuttle Pharmaceuticals Holdings Cash from Financing (TTM): -0.5137M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.5137M |
| December 31, 2023 | 2.570M |
| September 30, 2023 | 2.881M |
| June 30, 2023 | 13.00M |
| March 31, 2023 | 13.14M |
| Date | Value |
|---|---|
| December 31, 2022 | 10.62M |
| September 30, 2022 | 11.14M |
| June 30, 2022 | 1.141M |
| March 31, 2022 | 1.141M |
| December 31, 2021 | 0.6879M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.5137M
Minimum
Mar 2024
13.14M
Maximum
Mar 2023
5.581M
Average
2.726M
Median
Cash from Financing (TTM) Benchmarks
| Bioxytran Inc | 0.5659M |
| NovaBay Pharmaceuticals Inc | 1.313M |
| Palatin Technologies Inc | 14.71M |
| iBio Inc | 10.68M |
| Theriva Biologics Inc | 0.68M |